A Review of Vitamin A Supplementation in South Sudan: Successes, Challenges, and Opportunities for the Way Forward

Barriers and facilitators to the implementation of vitamin A supplementation programs in Africa: A systematic review

Background: Vitamin A deficiency (VAD) impacts over 50% of children aged 6-59 months in sub-Saharan Africa, causing severe health issues. Despite the importance of vitamin A supplementation (VAS) programs, barriers limit their effectiveness, making it essential to understand these factors for better outcomes. Aim: This systematic review aimed to identify the barriers and facilitators to VAS programs in Africa, using the Consolidated Framework for Implementation Research (CFIR) to conceptualize the findings. Methods: A comprehensive search was conducted across OVID Embase, OVID Medline, Web of Science Core Collection, Scopus, CINAHL and CAB Direct. Studies were excluded if they did not report VAS administration via capsules or droplets in large-scale programs or omitted discussions on implementation barriers and facilitators. Results: The search yielded 4377 citations, with 10 studies meeting eligibility criteria, published from 2002 to 2021 across 12 countries. The most frequently represented were Ethiopia and Zimbabwe. A total of nine barriers and seven facilitators to VAS programs were identified. The most frequently cited barriers were capsule stock-outs, limited resources and lack of incentive for staff, while the most frequently cited facilitators were Child Health Days and involvement of community-based health workers. The key CFIR constructs associated with these findings were Tailoring Strategies, Incentive Systems and Available Resources. Conclusion: The barriers and facilitators identified in this review offer valuable insights for improving VAS coverage and implementation in Africa. Tailoring implementation strategies based on these findings can enhance the effectiveness and coverage of VAS programs.

Randomized Controlled Clinical Trial of Pediatric Pneumococcus and Hepatitis A Vaccinations With or Without a High-Dose Oral Vitamin A Supplement

Previous studies have shown that high-dose vitamin supplements can improve vaccine-induced immune responses and pathogen protection in the context of vitamin deficiencies. To further elucidate the influence of vitamin supplements on immune responses toward pediatric vaccines, we performed a randomized controlled clinical trial (PCVIT) of 20 healthy children 1-4 years of age in Memphis, Tennessee. Study participants received a booster vaccine for pneumococcus and a primary vaccine for hepatitis A virus with or without a high-dose, oral, liquid supplement of 10,000 IU retinyl palmitate. We found that the children enrolled in PCVIT had higher baseline vitamin levels than previously described older children and adults living in Memphis. Only one child in PCVIT had a serum retinol level of less than 0.3 µg/mL. The children frequently consumed milk and baby foods that were likely vitamin-fortified, providing an explanation for the relatively high vitamin levels. Most children in PCVIT responded well to pneumococcus and hepatitis A vaccines by pathogen-specific antibody upregulation. The one child with a serum retinol level below 0.3 µg/mL did not receive a vitamin supplement and exhibited the lowest fold-change in antibody responses toward pneumococcal serotypes. A correlation matrix encompassing demographics, vitamin levels, vaccine-induced immune responses, C-reactive protein, and total serum immunoglobulin isotypes, including IgG2 and IgA, identified variables associated with vaccination outcomes. Perhaps because children were predominantly retinol-sufficient at baseline, the high-dose vitamin A supplement exhibited no benefit to vaccine-induced immune responses. In fact, when vitamin supplemented and vitamin unsupplemented groups were compared among participants with the highest baseline retinol levels, there was a trend toward weaker vaccine-induced immune responses in the vitamin supplemented group. Results encourage the performance of larger clinical studies before high-dose vitamin supplements are recommended for populations that are otherwise vitamin-replete.

Subnational estimates of vitamin A supplementation coverage in children: a geospatial analysis of 45 low- and middle-income countries

OBJECTIVES

Vitamin A supplementation (VAS) can protect children from the adverse health consequences of vitamin A deficiency. Granular data on VAS coverage can guide global and national efforts to achieve universal VAS coverage. To provide geographically precise targeting of VAS programs and to monitor progress in reducing geographic disparities, we aimed to create high-resolution (5 × 5 km2) maps of VAS coverage in children under 5 years across VAS priority countries.

STUDY DESIGN

We used cross-sectional data from the Demographic and Health Surveys (DHS) program.

METHODS

We used data from the DHS program for United Nations Children's Fund -designated VAS priority countries between 2000 and 2017 with data available from 2005 or later. The outcome variable was the proportion of children under 5 years who received a vitamin A dose in each sampled cluster. We applied a Bayesian geostatistical approach incorporating geographic, climatic, and nutritional covariates to estimate VAS coverage for each cell. We estimated and mapped absolute VAS coverage, Bayesian uncertainty intervals, and exceedance probabilities.

RESULTS

Our sample included countries from Latin America and the Caribbean, Asia, and Africa. Most countries had estimated VAS coverage levels <70%, and our exceedance probabilities indicated high certainty that our estimates fell below this threshold in most grid cells. International variations were most notable in the Latin America and the Caribbean region and Africa. Intranational variations were greatest in some South Asian and West and Central African countries.

CONCLUSIONS

These prevalence and exceedance maps, especially used with data on indicators of VAS need, could help to improve equity.

Exploring Barriers to Vitamin A Supplementation Uptake and Program Implementation Among Children Aged 6-59 Months in Ethiopia: A Qualitative Approach

Background: Children in Ethiopia do not receive the recommended dose of vitamin A supplementation (VAS). Objective: This study aimed to explore the barriers to VAS uptake and program implementation among children aged 6-59 months in Ethiopia. Methods: Data were collected qualitatively using focus group discussions and in-depth interviews. The data were audio-recorded, transcribed, and inductively coded. The results were displayed using thematic analysis and the well-spoken verbatim of the respondents. Results: The barriers to VAS uptake were low parental awareness of the program and low interest or motivation, low promotion of the program among health professionals, an excessive workload for health extension workers, and low professional attention to VAS compared to other health services. Conclusion: Both client-side and supply-side issues posed significant obstacles to the uptake of VAS. It is important to educate mothers about VAS. Health workers should receive refresher training to raise their level of concern about VAS's importance and its schedule. It's crucial to initiate outreach programs for remote communities. The departmentalization of health extension packages will improve service and access.